Bio-Rad Laboratories | BIO - Interest Expense On Debt


Bio-Rad Laboratories reported $12.1M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
Agilent USD 25M 0 Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Bio Techne USD 3.6M 1.19M Jun/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Charles River Laboratories USD 30.34M 3.6M Jun/2026
Danaher USD 107M 44M Jun/2026
General Electric Aerospace USD 496M 271M Dec/2025
Illumina USD 24M 2M Mar/2026
IQVIA Holdings USD 197M 5M Jun/2026
Laboratory Of America USD 61.1M 6M Jun/2026
Merck USD 525M 46M Jun/2026
Mettler Toledo International USD 17.25M 239K Jun/2026
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Repligen USD 5.66M 85K Jun/2026
Revvity USD 22.99M 1.73M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
Siemens EUR 371M 64M Jun/2026
Standard Biotools USD 5K 5K Dec/2025
Thermo Fisher Scientific USD 354M 11M Mar/2026
Tosoh JPY 884M 65M Sep/2025
Waters USD 55M 13M Jun/2026